P A Palmer Selected Research

Neoplasms (Cancer)

11/2006	A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumors.
6/2002	Phase I clinical and pharmacologic study of chronic oral administration of the farnesyl protein transferase inhibitor R115777 in advanced cancer.
1/2002	Evaluation of the bioequivalence of tablets and capsules containing the novel anticancer agent R115777 (Zarnestra) in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P A Palmer Research Topics

Disease

3	Neoplasms (Cancer) 11/2006 - 01/2002
2	Diarrhea 11/2006 - 10/2004
2	Neutropenia 11/2006 - 10/2004
1	Thrombocytopenia (Thrombopenia) 10/2004
1	Exanthema (Rash) 10/2004
1	Colorectal Neoplasms (Colorectal Cancer) 10/2004
1	Carcinoma (Carcinomatosis) 06/2002
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2002
1	Sleepiness 05/2002
1	Fever (Fevers) 04/2000
1	Mucositis 04/2000

Drug/Important Bio-Agent (IBA)

4	tipifarnib (R115777)IBA 11/2006 - 01/2002
3	TransferasesIBA 11/2006 - 06/2002
2	Proteins (Proteins, Gene)FDA Link 11/2006 - 06/2002
2	laniquidar (R101933)IBA 05/2002 - 04/2000
1	Capecitabine (Xeloda)FDA Link 11/2006
1	Biological ProductsIBA 11/2006
1	Carcinoembryonic AntigenIBA 06/2002
1	Codon (Codons)IBA 06/2002
1	PlatinumIBA 06/2002
1	Tumor Biomarkers (Tumor Markers)IBA 06/2002
1	TabletsIBA 01/2002
1	Capsules (Microcapsules)IBA 01/2002
1	Antineoplastic Agents (Antineoplastics)IBA 01/2002
1	Docetaxel (Taxotere)FDA Link 04/2000

Therapy/Procedure

1	Oral Administration 06/2002